ONESOURCE
ONESOURCE · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for ONESOURCE quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Updates
14 Jul 2026
Updates
09 Jul 2026
General Updates
09 Jul 2026
Updates
02 Jul 2026
Trading Window
24 Jun 2026
Disclosure under SEBI Takeover Regulations
17 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
20 May 2026
Updates
19 May 2026
Updates
19 May 2026
Updates
16 May 2026
Copy of Newspaper Publication
15 May 2026
Analysts/Institutional Investor Meet/Con. Call Updates
13 May 2026
Press Release
13 May 2026
Investor Presentation
13 May 2026
General Updates
13 May 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
No corporate actions available from NSE right now.
Board Meetings
13 May 2026
OneSource Specialty Pharma Limited has informed the Exchange about Board Meeting to be held on 13-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 .
13 May 2026
To consider and approve the financial results for the period ended March 31, 2026
13 May 2026
OneSource Specialty Pharma Limited has informed the Exchange about Board Meeting to be held on 13-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 .
23 Jan 2026
ONESOURCE SPECIALTY PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 23-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
23 Jan 2026
ONESOURCE SPECIALTY PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 23-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
23 Jan 2026
ONESOURCE SPECIALTY PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 23-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
23 Jan 2026
To consider and approve the financial results for the period ended December 31, 2025
11 Nov 2025
To consider and approve the financial results for the period ended September 30, 2025